Benzofuroxane derivatives as multi-effective agents for the treatment of cardiovascular diabetic complications. Synthesis, functional evaluation, and molecular …
…, F Da Settimo, E Novellino, C La Motta
Index: Ramunno, Anna; Cosconati, Sandro; Sartini, Stefania; Maglio, Vita; Angiuoli, Sara; La Pietra, Valeria; Di Maro, Salvatore; Giustiniano, Mariateresa; La Motta, Concettina; Da Settimo, Federico; Marinelli, Luciana; Novellino, Ettore European Journal of Medicinal Chemistry, 2012 , vol. 51, p. 216 - 226
Full Text: HTML
Citation Number: 12
Abstract
Diabetes mellitus is the major risk factor for cardiovascular disorders. Aldose reductase, the rate-limiting enzyme of the polyol pathway, plays a key role in the pathogenesis of diabetic complications. Accordingly, inhibition of this enzyme is emerging as a major therapeutic strategy for the treatment of hyperglycemia-induced cardiovascular pathologies. In this study, we describe a series of 5 (6)-substituted benzofuroxane derivatives, 5a–k, m, ...
Related Articles:
[Shi, Feng; Tse, Man Kin; Zhou, Shaolin; Pohl, Marga-Martina; Radnik, Joerg; et al. Journal of the American Chemical Society, 2009 , vol. 131, p. 1775 - 1779]